UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid

dc.contributor.authorFarboudi, Amirnezam
dc.contributor.authorMahboobnia, Khadijeh
dc.contributor.authorChogan, Faraz
dc.contributor.authorKarimi, Mahsa
dc.contributor.authorAskari, Anis
dc.contributor.authorBanihashem, Solmaz
dc.contributor.authorIrani, Mohammad
dc.date.accessioned2026-02-06T18:38:13Z
dc.date.issued2020
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractDoxorubicin (DOX) and folic acid (FA) were incorporated into the UiO-66 metal organic framework (MOF) and following were loaded into the carboxymethyl chitosan/poly ethylene oxide (PEO)/polyurethane core-shell nanofibers for controlled release of DOX and FA toward MCF-7 cells death. The synthesized nanocarriers were characterized using TEM, XRD, and SEM analysis. The drug loading efficiency and release profiles of DOX/MOF and FA/MOF from synthesized nanofibers have been investigated. The fitting of kinetic data by the pharmacokinetic models demonstrated the non-Fickian diffusion from nanofibers and Fickian diffusion from core-shell fibers. The cytotoxicity of synthesized nanofibers toward MCF-7 cancer cells was evaluated using DAPI staining, MTT assay and flow cytometry tests to investigate the simultaneous use of DOX and FA in the nanofibrous matrix for MCF-7 cells death in vitro. The maximum cell death using DOX-FA loaded-core-shell fibers produced by coaxial electrospinning method under 0.3, 0.5 and 0.8 mLh(-1) shell flow rates were found to be 82 +/- 0.7, 83 +/- 0.5 and 87 +/- 0.5% after 168, 240 and 240 h, respectively. The cytotoxicity results indicated that the co-delivery of DOX and FA into the core-shell fibers could be widely used for various cancers treatment. (c) 2020 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.ijbiomac.2020.02.067
dc.identifier.endpage188
dc.identifier.issn0141-8130
dc.identifier.issn1879-0003
dc.identifier.orcid0000-0003-4135-7594
dc.identifier.orcid0009-0000-5718-9199
dc.identifier.orcid0000-0001-8680-8307
dc.identifier.orcid0000-0002-6180-8412
dc.identifier.pmid32045607
dc.identifier.scopus2-s2.0-85079245060
dc.identifier.scopusqualityQ1
dc.identifier.startpage178
dc.identifier.urihttps://doi.org/10.1016/j.ijbiomac.2020.02.067
dc.identifier.urihttps://hdl.handle.net/11129/12838
dc.identifier.volume150
dc.identifier.wosWOS:000525869500019
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofInternational Journal of Biological Macromolecules
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectCarboxymethyl chitosan
dc.subjectUiO-66 metal organic framework
dc.subjectCore-shell nanofibers
dc.subjectDoxorubicin
dc.subjectFolic acid
dc.titleUiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid
dc.typeArticle

Files